Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
US Department of Justice
Julphar
Baxter
Cipla
Fish and Richardson
Fuji
Queensland Health
AstraZeneca

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089685

« Back to Dashboard

NDA 089685 describes PERPHENAZINE, which is a drug marketed by Pharm Assoc, Ani Pharms Inc, Mylan Pharms Inc, Sandoz, Vintage Pharms, Watson Labs Inc, Wilshire Pharms Inc, Fosun Pharma, Ivax Sub Teva Pharms, Mylan, Par Pharm, Sun Pharm Industries, and Watson Labs, and is included in forty-five NDAs. It is available from fifteen suppliers. Additional details are available on the PERPHENAZINE profile page.

The generic ingredient in PERPHENAZINE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.
Summary for 089685
Tradename:PERPHENAZINE
Applicant:Sandoz
Ingredient:perphenazine
Patents:0
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details
Pharmacology for NDA: 089685
Ingredient-typePhenothiazines
Medical Subject Heading (MeSH) Categories for 089685
Suppliers and Packaging for NDA: 089685
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PERPHENAZINE perphenazine TABLET;ORAL 089685 ANDA Sandoz Inc 0781-1048 N 0781-1048-01
PERPHENAZINE perphenazine TABLET;ORAL 089685 ANDA Sandoz Inc 0781-1048 N 0781-1048-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength8MG
Approval Date:Dec 8, 1988TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Dec 8, 1988TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG
Approval Date:Dec 8, 1988TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Healthtrust
Teva
Fish and Richardson
Mallinckrodt
Covington
Argus Health
Dow
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.